248 related articles for article (PubMed ID: 8813679)
21. Cloning and characterization of angiotensin converting enzyme related dipeptidylcarboxypeptidase from Leishmania donovani.
Goyal N; Duncan R; Selvapandiyan A; Debrabant A; Baig MS; Nakhasi HL
Mol Biochem Parasitol; 2006 Feb; 145(2):147-57. PubMed ID: 16257064
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a subunit of the outer dynein arm docking complex necessary for correct flagellar assembly in Leishmania donovani.
Harder S; Thiel M; Clos J; Bruchhaus I
PLoS Negl Trop Dis; 2010 Jan; 4(1):e586. PubMed ID: 20126266
[TBL] [Abstract][Full Text] [Related]
23. Molecular cloning, characterization and overexpression of two distinct cysteine protease cDNAs from Leishmania donovani chagasi.
Omara-Opyene AL; Gedamu L
Mol Biochem Parasitol; 1997 Dec; 90(1):247-67. PubMed ID: 9497047
[TBL] [Abstract][Full Text] [Related]
24. Expression and subcellular localization of cpn60 protein family members in Leishmania donovani.
Schlüter A; Wiesgigl M; Hoyer C; Fleischer S; Klaholz L; Schmetz C; Clos J
Biochim Biophys Acta; 2000 Apr; 1491(1-3):65-74. PubMed ID: 10760571
[TBL] [Abstract][Full Text] [Related]
25. Cloning and characterization of differentially expressed genes from in vitro-grown 'amastigotes' of Leishmania donovani.
Joshi M; Dwyer DM; Nakhasi HL
Mol Biochem Parasitol; 1993 Apr; 58(2):345-54. PubMed ID: 8479459
[TBL] [Abstract][Full Text] [Related]
26. Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections.
Ghosh A; Zhang WW; Matlashewski G
Vaccine; 2001 Oct; 20(1-2):59-66. PubMed ID: 11567746
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of Leishmania donovani in host-free system: analysis of signal perception and response.
Barak E; Amin-Spector S; Gerliak E; Goyard S; Holland N; Zilberstein D
Mol Biochem Parasitol; 2005 May; 141(1):99-108. PubMed ID: 15811531
[TBL] [Abstract][Full Text] [Related]
28. Detection and characterization of an albumin-like protein in Leishmania donovani.
Laha B; Verma AK; Biswas B; Sengodan SK; Rastogi A; Willard B; Ghosh M
Parasitol Res; 2019 May; 118(5):1609-1623. PubMed ID: 30903348
[TBL] [Abstract][Full Text] [Related]
29. Cloning, expression and antigenicity of the L. donovani reductase.
Jensen AT; Kemp K; Theander TG; Handman E
APMIS; 2001 Jun; 109(6):461-8. PubMed ID: 11506479
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase A signaling during bidirectional axenic differentiation in Leishmania.
Bachmaier S; Witztum R; Tsigankov P; Koren R; Boshart M; Zilberstein D
Int J Parasitol; 2016 Feb; 46(2):75-82. PubMed ID: 26460237
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the expression profiles of promastigotes and axenic amastigotes in Leishmania donovani using serial analysis of gene expression.
Li Q; Zhao Y; Ni B; Yao C; Zhou Y; Xu W; Wang Z; Qiao Z
Parasitol Res; 2008 Sep; 103(4):821-8. PubMed ID: 18568446
[TBL] [Abstract][Full Text] [Related]
32. Stage-specific expression of the proline-alanine transporter in the human pathogen Leishmania.
Liburkin-Dan T; Schlisselberg D; Fischer-Weinberger R; Pescher P; Inbar E; Ephros M; Rentsch D; Späth GF; Zilberstein D
Mol Biochem Parasitol; 2018 Jun; 222():1-5. PubMed ID: 29655799
[TBL] [Abstract][Full Text] [Related]
33. Comparative proteome analysis of Leishmania donovani at different stages of transformation from promastigotes to amastigotes.
Thiel M; Bruchhaus I
Med Microbiol Immunol; 2001 Nov; 190(1-2):33-6. PubMed ID: 11770106
[TBL] [Abstract][Full Text] [Related]
34. An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans.
Goyard S; Segawa H; Gordon J; Showalter M; Duncan R; Turco SJ; Beverley SM
Mol Biochem Parasitol; 2003 Aug; 130(1):31-42. PubMed ID: 14550894
[TBL] [Abstract][Full Text] [Related]
35. [Molecular cloning and localization of Leishmania donovani expression site associated genes-like protein].
Liu P; Zhang RG; Zhang J; Jing BQ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2014 Oct; 32(5):327-33. PubMed ID: 25726590
[TBL] [Abstract][Full Text] [Related]
36. Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani: a key molecular target in antileishmanial therapy.
Das A; Dasgupta A; Sharma S; Ghosh M; Sengupta T; Bandopadhyay S; Majumder HK
Nucleic Acids Res; 2001 May; 29(9):1844-51. PubMed ID: 11328867
[TBL] [Abstract][Full Text] [Related]
37. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
Mukherjee M; Bhattacharyya A; Duttagupta S
Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
[TBL] [Abstract][Full Text] [Related]
38. Cyclosporin A treatment of Leishmania donovani reveals stage-specific functions of cyclophilins in parasite proliferation and viability.
Yau WL; Blisnick T; Taly JF; Helmer-Citterich M; Schiene-Fischer C; Leclercq O; Li J; Schmidt-Arras D; Morales MA; Notredame C; Romo D; Bastin P; Späth GF
PLoS Negl Trop Dis; 2010 Jun; 4(6):e729. PubMed ID: 20614016
[TBL] [Abstract][Full Text] [Related]
39. Cloning and expression of the adenine phosphoribosyltransferase gene from Leishmania donovani.
Allen T; Hwang HY; Wilson K; Hanson S; Jardim A; Ullman B
Mol Biochem Parasitol; 1995 Oct; 74(1):99-103. PubMed ID: 8719249
[No Abstract] [Full Text] [Related]
40. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis.
Burns JM; Shreffler WG; Benson DR; Ghalib HW; Badaro R; Reed SG
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):775-9. PubMed ID: 8421715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
